Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Current Deferred Revenue: 2024-2025

Historic Current Deferred Revenue for Incannex Healthcare (IXHL) over the last 2 years, with Sep 2025 value amounting to $30,000.

  • Incannex Healthcare's Current Deferred Revenue fell 49.15% to $30,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $30,000, marking a year-over-year decrease of 49.15%. This contributed to the annual value of $30,000 for FY2025, which is 64.71% down from last year.
  • Latest data reveals that Incannex Healthcare reported Current Deferred Revenue of $30,000 as of Q3 2025, which was down 0.00% from $30,000 recorded in Q2 2025.
  • Incannex Healthcare's Current Deferred Revenue's 5-year high stood at $85,000 during Q2 2024, with a 5-year trough of $27,000 in Q4 2024.
  • Moreover, its 2-year median value for Current Deferred Revenue was $30,000 (2025), whereas its average is $43,167.
  • Data for Incannex Healthcare's Current Deferred Revenue shows a maximum YoY crashed of 64.71% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Incannex Healthcare's Current Deferred Revenue stood at $27,000 in 2024, then plummeted by 49.15% to $30,000 in 2025.
  • Its last three reported values are $30,000 in Q3 2025, $30,000 for Q2 2025, and $28,000 during Q1 2025.